Trio, including former Novartis exec, accused of bribery to the tune of over HK$1.5 million
pharmafile | November 28, 2017 | News story | Manufacturing and Production, Sales and Marketing | Novartis, bribery, illegal
A trio, including a former Senior Medical Representative at Novartis, have been charged over allegedly conspiring to offer and accept bribes of more than HK$1.5 million (US$192,000) in relation to the sale of pharmaceutical products, according to Hong Kong’s Independent Commission Against Corruption.
A joint charge alleges that, between January 2014 and April 2015, 42-year-old Gavin Wong Chun-yin, formerly of Novartis, unlawfully accepted a total of HK$946,750 from 52-year-old Wong Chung-sum, Operator of Hygience Medicine Limited (HML), in exchange for supplying Novartis’ drugs to HML.
A second charge accuses Tsoi Lai-ngan, 58 of Man Hong Dispensary (MHD), of unlawfully giving HK$563,000 to Gavin Wong over a 10-year period from 2005 to 2015, again for supplying Novartis drugs to MHD.
The three accused will appear at the Eastern Magistracy on 30 November.
Matt Fellows
Related Content
Novartis shares new data about Fabhalta for IgAN treatment
Novartis has announced new results from a pre-specified interim analysis of its phase 3 APPLAUSE-IgAN …
Novartis shares new data for Zolgensma in children with SMA
Novartis has announced new data to continue the support of the clinical benefits of Zolgensma …
Novartis to acquire MorphoSys AG for €2.7bn
Novartis has announced that it has entered an agreement to acquire MorphoSys AG for €2.7bn, …